Arca
Skip to content

MS4A1: B-lymphocyte antigen CD20

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes.

  • Drugs that act on it: 18
  • With a US drug page: 7
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
EpcoritamabApprovedB-lymphocyte antigen CD20 binding agentBinding agentBoxed warning
GlofitamabApprovedB-lymphocyte antigen CD20 binding agentBinding agentBoxed warning
MosunetuzumabApprovedB-lymphocyte antigen CD20 binding agentBinding agentBoxed warning
ObinutuzumabApprovedB-lymphocyte antigen CD20 binding agentBinding agentBoxed warning
OcrelizumabApprovedB-lymphocyte antigen CD20 binding agentBinding agent—
OfatumumabApprovedB-lymphocyte antigen CD20 binding agentBinding agentBoxed warning
UblituximabApprovedB-lymphocyte antigen CD20 binding agentBinding agent—
FBT-A05—B-lymphocyte antigen CD20 cross-linking agentCross-linking agent—
LFB-R603—B-lymphocyte antigen CD20 binding agentBinding agent—
MT-3724—B-lymphocyte antigen CD20 binding agentBinding agent—
Ocaratuzumab—B-lymphocyte antigen CD20 binding agentBinding agent—
Odronextamab—B-lymphocyte antigen CD20 binding agentBinding agent—
Rituximab—B-lymphocyte antigen CD20 binding agentBinding agentBoxed warning
Tositumomab—B-lymphocyte antigen CD20 binding agentBinding agentBoxed warning
Tositumomab 131I—B-lymphocyte antigen CD20 binding agentBinding agent—
TRU-015—B-lymphocyte antigen CD20 binding agentBinding agent—
Veltuzumab—B-lymphocyte antigen CD20 binding agentBinding agent—
Yttrium y 90 ibritumomab tiuxetan—B-lymphocyte antigen CD20 binding agentBinding agentBoxed warning

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Neoplasm
0.59
B-cell non-Hodgkin lymphoma
0.52
Common variable immunodeficiency
0.48

Drugs and mechanisms are from ChEMBL CHEMBL2058 (CC BY-SA 3.0). Gene name, function (UniProt P11836, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.